8-K

Abacus Life, Inc.

Date: August 25, 2023

/s/ Jay Jackson

Jay Jackson

Chief Executive Officer

0001193125-23-221545.txt : 20230825 0001193125-23-221545.hdr.sgml : 20230825 20230825163106 ACCESSION NUMBER: 0001193125-23-221545 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230825 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abacus Life, Inc. CENTRAL INDEX KEY: 0001814287 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 851210472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39403 FILM NUMBER: 231208810 BUSINESS ADDRESS: STREET 1: 2101 PARK CENTER DRIVE, SUITE 170 CITY: ORLANDO STATE: FL ZIP: 32835 BUSINESS PHONE: (800) 561-4148 MAIL ADDRESS: STREET 1: 2101 PARK CENTER DRIVE, SUITE 170 CITY: ORLANDO STATE: FL ZIP: 32835 FORMER COMPANY: FORMER CONFORMED NAME: East Resources Acquisition Co DATE OF NAME CHANGE: 20200605 8-K 1 d452186d8k.htm 8-K 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 25, 2023

Abacus Life, Inc.

(Exact name of registrant as specified in its charter)


Delaware	001-39403	85-1210472
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification Number)

2101 Park Center Drive, Suite 170

Orlando, Florida 32835

(800) 561-4148

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbols	Name of each exchange on which registered
Common stock, par value $0.0001 per share	ABL	The NASDAQ Stock Market LLC
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share	ABLLW	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 2.02. Results of Operations and Financial Condition

On August 25, 2023, Abacus Life, Inc. released the historical second quarter 2022 financials for Abacus Settlements, LLC and Longevity Market Assets, LLC (the predecessor companies which merged with and into the Company effective as of June 30, 2023 and which currently comprise all of the business of the Company). The full text of this release is included here as Exhibit 99.1 hereto.

Item 9.01. Financial Statement and Exhibits.

(a)

Exhibits.


99.1		Historical Financial Release dated August 25, 2023

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall Exhibit 99.1 be deemed incorporated by reference into any filing of the Company under the Securities Act, in each case, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as expressly set forth in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

EX-99.1 2 d452186dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

ABACUS LIFE PRESENTS HISTORICAL QUARTERLY AND FULL YEAR 2022 FINANCIALS

ORLANDO, Fla. – August 25, 2023 – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today is releasing its unaudited historical quarterly and full year 2022 financials for Abacus Settlements, LLC (“AS”) and Longevity Market Assets, LLC (“LMA” and, together with AS, the “Predecessor Companies”). The Predecessor Companies are the predecessor companies which merged with and into the Company effective as of June 30, 2023 and which currently comprise all of the business of the Company. In addition, for illustrative purposes only, the Company is providing historical quarterly and full year 2022 financials of the Predecessor Companies on a pro forma combined basis (the “Pro Forma Financials”).

The Company is also providing financial information from last year to permit investors and analysts to understand more about the financial results for the business from 2022 for comparison purposes. The financial information related to Abacus Settlements, LLC and Longevity Market Assets, LLC is being presented for informational purposes only and should not be deemed to imply future performance of the Company. Anyone interested in the Company’s current year financial information should consult its Quarterly Report on Form 10-Q.

Safe Harbor Statement

Statements made in this press release that are not historical facts, including statements accompanied by words such as “will,” “believe,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” “prospects,” or similar words, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the Company’s plans and performance. These statements are based on management’s estimates, assumptions and projections as of the date of this release and are not guarantees of future performance. Actual results may differ materially from the results expressed or implied in these statements as the result of risks, uncertainties and other factors including, but not limited to: the fact that our loss reserves are bases on estimates and may be inadequate to cover our actual losses; the failure to properly price our insurance policies; the geographic concentration of our business; the cyclical nature of our industry; the impact of regulation on our business; the effects of competition; failing to sustain our relationships with independent agencies; the failure to meet our investment objectives; the inability to acquire additional capital on favorable terms; the effects of acts of terrorism and the factors set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including the Annual Report on Form 10-K and Quarterly Report on Form 10-Q and subsequent periodic reports. The Company cautions you not to place undue reliance on the forward-looking statements contained in this release. Any forward–looking statements speak only as of their dates. The Company does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.

Non-GAAP Financial Measures

This press release includes references to Adjusted EBITDA, a non-GAAP financial measure. Non-GAAP financial measures are financial measures that are derived from the consolidated financial statements, but that are not presented in accordance with generally accepted accounting principles in the United States (GAAP). The Company uses this non-GAAP financial measure and other key metrics internally to facilitate analysis of financial and business trends and for internal planning and forecasting purposes. The Company believes this non-GAAP financial measure, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance by excluding certain items that may not be indicative of the business, results of operations, or outlook. However, this non- GAAP financial measure has limitations as an analytical tool and is presented for supplemental informational purposes only. It should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. In particular, other companies, including companies in the Company’s industry, may report Adjusted EBITDA or similarly titled measures but calculate them differently, which reduces its usefulness as comparative measures.

Reconciliation of GAAP Measures to Non-GAAP Measures

Set forth below Net Income in each of the following tables is a reconciliation of Adjusted EBITDA to GAAP Net Income, the most directly comparable GAAP measure, for each of the periods presented.

Basis of Pro Forma Presentation

The Pro Forma Financials have been adjusted to give pro forma effect to the combination of the Predecessor Companies with the Company. The adjustments in the Pro Forma Financials have been identified and presented to provide relevant information necessary for an accurate understanding of the Company following the mergers with the Predecessor Companies.

The Pro Forma Financials are provided for illustrative purposes only. The financial results may have been different had the Company and the Predecessor Companies always been combined. You should not rely on the Pro Forma Financials as being indicative of the historical results that would have been achieved had the Company and the Predecessor Companies always been combined or the future results that the Company will experience.

About Abacus

Abacus is a leading vertically integrated alternative asset manager specializing in life insurance products. Since 2004, the Company has purchased life insurance policies from consumers seeking liquidity and has actively managed those policies over time (via trading, holding, and/or servicing). With over $2.9 billion in face value of policies purchased, Abacus has helped thousands of clients maximize the value of their life insurance.

Over the past 19 years, the Company has built an institutionalized origination and portfolio management process that is supported by an 84-person team, long-term relationships with 78 institutional partners and 30,000 financial advisors, and the ability to operate in 49 states. The Company has serviced approximately $950 million in policies and has managed assets for large asset managers and third-party investment funds.

Abacus’ leadership team averages 20+ years of experience and consists of innovators since the life settlements industry’s inception in the mid-90s.

The Company is a proud member of the Life Insurance Settlements Association (LISA) and complies with HIPAA and privacy laws to maintain and protect confidentiality of financial, health, and medical information. Abacus is also proud to be a BBB Accredited Business with an A+ rating.

www.Abacuslife.com

Contact:

Abacus Life Investor Relations

investors@abacuslife.com

Abacus Life Public Relations

press@abacuslife.com


LONGEVITY MARKET ASSETS, LLC AND ABACUS SETTLEMENTS, LLC COMBINED
PROFORMA STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME
FY 2022

	Three months ended March 31,		Three months ended June 30,			Three months ended September 30,		Three months ended December 31,		Full Year
	2022 Q1		2022 Q2			2022 Q3		2022 Q4		2022
Revenues
Origination Revenue		7,322,747		5,691,916			6,031,481		6,157,319		25,203,463
Portfolio servicing revenue		570,905		419,422			382,245		98,400		1,470,972
Active management revenue
Investment Income from life insurance policies held using investment method		8,015,000		5,965,466			10,629,978		13,218,386		37,828,829
Change in fair value of life insurance policies (policies held using fair value method)		1,291,492		(1,291,492	)		3,801,031		1,612,721		5,413,751
Total active management revenue		9,306,492		4,673,974			14,431,008		14,831,106		43,242,581
Total revenues		17,200,144		10,785,312			20,844,734		21,086,826		69,917,016


Cost of revenues (excluding depreciation stated below)	6,635,650		4,238,051		5,618,972		6,313,464		22,806,136
Gross profit	10,564,495		6,547,262		15,225,762		14,773,362		47,110,880
Operating expenses:
Sales and marketing	630,000		1,019,498		14,905		931,737		2,596,140
General, administrative and other	2,381,512		2,213,550		2,343,877		2,801,889		9,740,828
Other operating expense	—		—		(2,141	)	—		(2,141	)
Depreciation	3,983		4,146		6,373		4,087		18,588
Change in fair value of debt	41,634		333,879		(1,235,032	)	950,238		90,719
Unrealized (gain) loss on policies	—		(3,305,505	)	3,305,505		—		—
Unrealized (gain) on investments	15,953		1,039,022		246,846		(256,199	)	1,045,623
Total operating expenses	3,073,082		1,304,590		4,680,334		4,431,751		13,489,758
Operating Income	7,491,412		5,242,671		10,545,428		10,341,610		33,621,122
Other (expense) / income
Other (expense)	(114,792	)	(127,181	)	42,288		(147,054	)	(346,740	)
Interest (expense)	0		—		(2,954	)	(48,661	)	(51,615	)
Interest income	548		599		358		2,167		3,672
Total other (expense) / income	(114,244	)	(126,582	)	39,691		(193,547	)	(394,682	)


Net income before tax	7,377,169		5,116,089		10,585,120		10,148,063		33,226,440
Income tax (benefit)	1,325		296,806		242,544		351,286		891,961
Net income	7,375,844		4,819,283		10,342,576		9,796,777		32,334,479
Less: Net income (loss) attributable to non-controlling interests	—		406,641		405,967		(27,844	)	784,764
Net income attributable to Longevity Market Assets, LLC	7,375,844		4,502,884		9,936,609		9,824,621		31,549,715
Net income	7,375,844		4,819,283		10,342,576		9,796,777		32,334,479
Depreciation and amortization expense	3,983		4,146		6,373		4,087		18,588
Income tax	1,325		296,806		242,544		351,286		891,961
Other (expense)	114,792		127,181		(42,288	)	147,054		346,740
Interest expense	(0	)	—		2,954		48,661		51,615
Interest income	(548	)	(599	)	(358	)	(2,167	)	(3,672	)
Loss on change in fair value of debt	41,634		333,879		(1,235,032	)	950,238		90,719
Unrealized (gain) on investments	15,953		1,039,022		246,846		(256,199	)	1,045,623
Adjusted EBITDA	7,552,983		6,619,719		9,563,615		11,039,736		34,776,053

LONGEVITY MARKET ASSETS, LLC

STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

FY 2022


	Three months ended March 31,		Three months ended June 30,			Three months ended September 30,		Three months ended December 31,		Full Year
	2022 Q1		2022 Q2			2022 Q3		2022 Q4		2022
Revenues
Portfolio servicing revenue
Related-party service revenue		200,905		419,253			132,220		65,921		818,299
Portfolio Servicing revenue		370,000		169			250,025		32,479		652,673
Total portfolio servicing revenue		570,905		419,422			382,245		98,400		1,470,972
Active management revenue
Investment Income from life insurance policies held using investment method		8,015,000		5,965,466			10,629,978		13,218,386		37,828,829
Change in fair value of life insurance policies (policies held using fair value method)		1,291,492		(1,291,492	)		3,801,031		1,612,721		5,413,751


Total active management revenue	9,306,492		4,673,974		14,431,008		14,831,106		43,242,581
Total revenues	9,877,397		5,093,396		14,813,253		14,929,506		44,713,553
Cost of revenues (excluding depreciation stated below)	1,419,956		666,119		1,754,894		2,404,163		6,245,131
Gross profit	8,457,441		4,427,277		13,058,360		12,525,344		38,468,422
Operating expenses:
Sales and marketing	630,000		1,019,498		14,905		931,737		2,596,140
General, administrative and other	641,205		5,499		59,816		359,883		1,066,403
Other operating expense	—		—		(2,141	)	—		(2,141	)
Depreciation	1,043		1,098		3,212		1,071		6,423
Change in fair value of debt	41,634		333,879		(1,235,032	)	950,238		90,719
Unrealized (gain) loss on policies	—		(3,305,505	)	3,305,505		—		—
Unrealized (gain) on investments	15,953		1,039,022		246,846		(256,199	)	1,045,623
Total operating expenses	1,329,835		(906,509	)	2,393,111		1,986,729		4,803,168
Operating Income	7,127,605		5,333,786		10,665,248		10,538,614		33,665,254
Other (expense) / income
Other (expense)	(114,792	)	(127,455	)	42,288		(147,054	)	(347,013	)


Interest (expense)	—		—		—		(42,798	)	(42,798	)
Interest income	—		—		—		1,474		1,474
Total other (expense) / income	(114,792	)	(127,455	)	42,288		(188,378	)	(388,337	)
Net income before tax	7,012,813		5,206,331		10,707,536		10,350,236		33,276,917
Income tax (benefit)	—		296,806		241,962		351,176		889,943
Net income	7,012,813		4,909,525		10,465,574		9,999,061		32,386,974
Less: Net income (loss) attributable to non-controlling interests	—		406,641		405,967		(27,844	)	784,764
Net income attributable to Longevity Market Assets, LLC	7,012,813		4,502,884		10,059,607		10,026,905		31,602,210
Net income	7,012,813		4,909,525		10,465,574		9,999,061		32,386,973
Depreciation and amortization expense	1,043		1,098		3,212		1,071		6,423
Income tax	—		296,806		241,962		351,176		889,943
Other (expense)	114,792		127,455		(42,288	)	147,054		347,013
Interest expense	—		—		—		42,798		42,798
Interest income	—		—		—		(1,474	)	(1,474	)
Loss on change in fair value of debt	41,634		333,879		(1,235,032	)	950,238		90,719
Unrealized (gain) on investments	15,953		1,039,022		246,846		(256,199	)	1,045,623
Adjusted EBITDA	7,186,236		6,707,785		9,680,275		11,233,724		34,808,019

ABACUS SETTLEMENTS, LLC

STATEMENT OF OPERATIONS

FY 2022


	Three months ended March 31,		Three months ended June 30,		Three months ended September 30,		Three months ended December 31,		Full Year
	2022 Q1		2022 Q2		2022 Q3		2022 Q4		2022
Revenue		2,441,680		743,388		1,766,853		2,098,086		7,050,007
Related party revenue		4,881,067		4,948,528		4,264,628		4,059,233		18,153,456
Total revenue		7,322,747		5,691,916		6,031,481		6,157,319		25,203,463
Cost of sales
Cost of sales (exclusive of items shown separately below)		2,308,688		956,625		933,089		1,340,069		5,538,470
Related party cost of sales		2,907,005		2,615,307		2,930,990		2,569,233		11,022,535
Total cost of sales		5,215,693		3,571,932		3,864,079		3,909,302		16,561,005
Gross profit		2,107,054		2,119,984		2,167,402		2,248,018		8,642,458
Operating expenses:
General and administrative expenses		1,740,307		2,208,051		2,284,061		2,442,006		8,674,425


Depreciation and amortization expense	2,940	3,048		3,161		3,016		12,165
Total operating expenses	1,743,247	2,211,099		2,287,222		2,445,022		8,686,590
Income (loss) from operations	363,807	(91,115	)	(119,820	)	(197,004	)	(44,132	)
Other income (expense)
Interest income	548	599		358		694		2,199
Interest expense	0	—		(2,954	)	(5,863	)	(8,817	)
Other income (expense)	—	273		—		—		273
Total other income (expense)	548	872		(2,596	)	(5,169	)	(6,345	)
Income before income taxes	364,356	(90,242	)	(122,417	)	(202,173	)	(50,477	)


Provision for income taxes		1,325			—			582			111			2,018
Net income and comprehensive income (loss)	$	363,031		$	(90,242	)	$	(122,999	)	$	(202,284	)	$	(52,494	)
Net income and comprehensive income (loss)	$	363,031		$	(90,242	)	$	(122,999	)	$	(202,284	)		(52,494	)
Depreciation and amortization expense		2,940			3,048			3,161			3,016			12,165
Provision for income taxes		1,325			—			582			111			2,018
Interest income		(548	)		(599	)		(358	)		(694	)		(2,199	)
Interest expense		0			—			(2,954	)		(5,863	)		(8,817	)
Adjusted EBITDA	$	366,747		$	(87,793	)	$	(122,567	)	$	(205,714	)	$	(49,327	)

EX-101.SCH 3 abl-20230825.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 4 abl-20230825_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 abl-20230825_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock Par Value 0.0001 Per Share [Member] Common Stock Par Value 0.0001 Per Share [Member] Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of 11.50 Per Share [Member] Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of 11.50 Per Share [Member] EX-101.PRE 6 abl-20230825_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information	Aug. 25, 2023
Document And Entity Information [Line Items]
Amendment Flag	false
Entity Central Index Key	0001814287
Document Type	8-K
Document Period End Date	Aug. 25, 2023
Entity Registrant Name	Abacus Life, Inc.
Entity Incorporation State Country Code	DE
Entity File Number	001-39403
Entity Tax Identification Number	85-1210472
Entity Address, Address Line One	2101 Park Center Drive
Entity Address, Address Line Two	Suite 170
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32835
City Area Code	800
Local Phone Number	561-4148
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Common Stock Par Value 0.0001 Per Share [Member]
Document And Entity Information [Line Items]
Security 12b Title	Common stock, par value $0.0001 per share
Trading Symbol	ABL
Security Exchange Name	NASDAQ
Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of 11.50 Per Share [Member]
Document And Entity Information [Line Items]
Security 12b Title	Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
Trading Symbol	ABLLW
Security Exchange Name	NASDAQ

XML 8 d452186d8k_htm.xml IDEA: XBRL DOCUMENT 0001814287 2023-08-25 2023-08-25 0001814287 abl:CommonStockParValue0.0001PerShareMember 2023-08-25 2023-08-25 0001814287 abl:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf11.50PerShareMember 2023-08-25 2023-08-25 false 0001814287 8-K 2023-08-25 Abacus Life, Inc. DE 001-39403 85-1210472 2101 Park Center Drive Suite 170 Orlando FL 32835 800 561-4148 false false false false Common stock, par value $0.0001 per share ABL NASDAQ Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share ABLLW NASDAQ true true EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #@@QE799!YDAD! #/ P M$P @ &D$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .."0 ) #X" #N% ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d452186d8k.htm abl-20230825.xsd abl-20230825_def.xml abl-20230825_lab.xml abl-20230825_pre.xml d452186dex991.htm http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d452186d8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 27 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "abl-20230825_def.xml" ] }, "inline": { "local": [ "d452186d8k.htm" ] }, "labelLink": { "local": [ "abl-20230825_lab.xml" ] }, "presentationLink": { "local": [ "abl-20230825_pre.xml" ] }, "schema": { "local": [ "abl-20230825.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 2, "memberStandard": 0, "nsprefix": "abl", "nsuri": "http://abacuslife.com/20230825", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d452186d8k.htm", "contextRef": "duration_2023-08-25_to_2023-08-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d452186d8k.htm", "contextRef": "duration_2023-08-25_to_2023-08-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "abl_CommonStockParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Par Value 0.0001 Per Share [Member]", "terseLabel": "Common Stock Par Value 0.0001 Per Share [Member]" } } }, "localname": "CommonStockParValue0.0001PerShareMember", "nsuri": "http://abacuslife.com/20230825", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "abl_DocumentAndEntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "localname": "DocumentAndEntityInformationLineItems", "nsuri": "http://abacuslife.com/20230825", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "abl_DocumentAndEntityInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "localname": "DocumentAndEntityInformationTable", "nsuri": "http://abacuslife.com/20230825", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "abl_WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf11.50PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of 11.50 Per Share [Member]", "terseLabel": "Warrants Each Whole Warrant Exercisable For One Share Of Common Stock At An Exercise Price Of 11.50 Per Share [Member]" } } }, "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf11.50PerShareMember", "nsuri": "http://abacuslife.com/20230825", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://abacuslife.com//20230825/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001193125-23-221545-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-221545-xbrl.zip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end